Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer

被引:69
作者
Kaur, Harsimar B. [1 ]
Guedes, Liana B. [1 ]
Lu, Jiayun [2 ]
Maldonado, Laneisha [1 ]
Reitz, Logan [1 ]
Barber, John R. [2 ]
De Marzo, Angelo M. [1 ,3 ,4 ]
Tosoian, Jeffrey J. [4 ]
Tomlins, Scott A. [5 ,6 ]
Schaeffer, Edward M. [4 ,7 ]
Joshu, Corinne E. [2 ]
Sfanos, Karen S. [1 ,3 ,4 ]
Lotan, Tamara L. [1 ,3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21218 USA
[4] Johns Hopkins Univ, Dept Urol, Sch Med, Baltimore, MD USA
[5] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[6] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA
[7] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA
关键词
EUROPEAN-AMERICAN MEN; MISMATCH-REPAIR DEFICIENCY; AFRICAN-AMERICAN; PROGNOSTIC-FACTOR; RADICAL PROSTATECTOMY; ANDROGEN RECEPTOR; LUNG-CARCINOMA; PD-1; BLOCKADE; FREE SURVIVAL; LYMPHOCYTES;
D O I
10.1038/s41379-018-0083-x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The inflammatory microenvironment plays an important role in the pathogenesis and progression of tumors and may be associated with somatic genomic alterations. We examined the association of tumor-infiltrating T-cell density with clinical-pathologic variables, tumor molecular subtype, and oncologic outcomes in surgically treated primary prostate cancer occurring in patients of European-American or African-American ancestry. We evaluated 312 primary prostate tumors, enriched for patients with African-American ancestry and high grade disease. Tissue microarrays were immunostained for CD3, CD8, and FOXP3 and were previously immunostained for ERG and PTEN using genetically validated protocols. Image analysis for quantification of T-cell density in tissue microarray tumor spots was performed. Automated quantification of T-cell densities in tumor-containing regions of tissue microarray spots and standard histologic sections were correlated (r = 0.73, p < 0.00001) and there was good agreement between visual and automated T-cell density counts on tissue microarray spots (r = 0.93, p < 0.00001). There was a significant correlation between CD3+, CD8+, and FOXP3+ T-cell densities (p < 0.00001), but these were not associated with most clinical or pathologic variables. Increased T-cell density was significantly associated with ERG positivity (median 309 vs. 188 CD3+ T cells/mm(2); p = 0.0004) and also with PTEN loss (median 317 vs. 192 CD3+ T cells/mm(2) ; p = 0.001) in the combined cohort of matched European-American and African-American ancestry patients. The same association or a similar trend was present in patients of both ancestries when analyzed separately. When the African-American patients from the matched race set were combined with a separate high grade set of African-American cases, there was a weak association of increased FOXP3+ T-cell densities with increased risk of metastasis in multivariable analysis. Though high T-cell density is associated with specific molecular subclasses of prostate cancer, we did not find an association of T-cell density with racial ancestry.
引用
收藏
页码:1539 / 1552
页数:14
相关论文
共 55 条
  • [1] A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer
    Ahearn, Thomas U.
    Pettersson, Andreas
    Ebot, Ericka M.
    Gerke, Travis
    Graff, Rebecca E.
    Morais, Carlos L.
    Hicks, Jessica L.
    Wilson, Kathryn M.
    Rider, Jennifer R.
    Sesso, Howard D.
    Fiorentino, Michelangelo
    Flavin, Richard
    Finn, Stephen
    Giovannucci, Edward L.
    Loda, Massimo
    Stampfer, Meir J.
    De Marzo, Angelo M.
    Mucci, Lorelei A.
    Lotan, Tamara L.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (02):
  • [2] The prognostic value of intraepithelial and stromal CD3-, CD117-and CD138-positive cells in non-small cell lung carcinoma
    Al-Shibli, Khalid
    Al-Saad, Samer
    Andersen, Sigve
    Donnem, Tom
    Bremnes, Roy M.
    Busund, Lill-Tove
    [J]. APMIS, 2010, 118 (05) : 371 - 382
  • [3] Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis
    Benzon, B.
    Zhao, S. G.
    Haffner, M. C.
    Takhar, M.
    Erho, N.
    Yousefi, K.
    Hurley, P.
    Bishop, J. L.
    Tosoian, J.
    Ghabili, K.
    Alshalalfa, M.
    Glavaris, S.
    Simons, B. W.
    Tran, P.
    Davicioni, E.
    Karnes, R. J.
    Boudadi, K.
    Antonarakis, E. S.
    Schaeffer, E. M.
    Drake, C. G.
    Feng, F.
    Ross, A. E.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (01) : 28 - 35
  • [4] Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms
    Bezzi, Marco
    Seitzer, Nina
    Ishikawa, Tomoki
    Reschke, Markus
    Chen, Ming
    Wang, Guocan
    Mitchell, Caitlin
    Ng, Christopher
    Katon, Jesse
    Lunardi, Andrea
    Signoretti, Sabina
    Clohessy, John G.
    Zhang, Jiangwen
    Pandolfi, Pier Paolo
    [J]. NATURE MEDICINE, 2018, 24 (02) : 165 - +
  • [5] Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival
    Bogunovic, Dusan
    O'Neill, David W.
    Belitskaya-Levy, Ilana
    Vacic, Vladimir
    Yu, Yi-Lo
    Adams, Sylvia
    Darvishian, Farbod
    Berman, Russell
    Shapiro, Richard
    Pavlick, Anna C.
    Lonardi, Stefano
    Zavadil, Jiri
    Osman, Iman
    Bhardwaj, Nina
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (48) : 20429 - 20434
  • [6] The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer
    Bromwich, EJ
    McArdle, PA
    Canna, K
    McMillan, DC
    McNicol, AM
    Brown, M
    Aitchison, M
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (10) : 1906 - 1908
  • [7] Expression of PD-L1 in Hormone-naive and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide
    Calagua, Carla
    Russo, Joshua
    Sun, Yue
    Schaefer, Rachel
    Lis, Rosina
    Zhang, Zhenwei
    Mahoney, Kathleen
    Bubley, Glenn J.
    Loda, Massimo
    Taplin, Mary-Ellen
    Balk, Steven P.
    Ye, Huihui
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (22) : 6812 - 6822
  • [8] Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
    Carver, Brett S.
    Tran, Jennifer
    Gopalan, Anuradha
    Chen, Zhenbang
    Shaikh, Safa
    Carracedo, Arkaitz
    Alimonti, Andrea
    Nardella, Caterina
    Varmeh, Shohreh
    Scardino, Peter T.
    Cordon-Cardo, Carlos
    Gerald, William
    Pandolfi, Pier Paolo
    [J]. NATURE GENETICS, 2009, 41 (05) : 619 - 624
  • [9] CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3+ regulatory T cells with respect to lethal prostate cancer
    Davidsson, Sabina
    Ohlson, Anna-Lena
    Andersson, Swen-Olof
    Fall, Katja
    Meisner, Allison
    Fiorentino, Michelangelo
    Andren, Ove
    Rider, Jennifer R.
    [J]. MODERN PATHOLOGY, 2013, 26 (03) : 448 - 455
  • [10] Microsatellite Instability as a Biomarker for PD-1 Blockade
    Dudley, Jonathan C.
    Lin, Ming-Tseh
    Le, Dung T.
    Eshleman, James R.
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (04) : 813 - 820